cases is now recommended at most institutions with a high expectation of satisfactory outcome.
For this reason, rigorous investigation into detecting epileptic foci is paramount. Electroencephalogram (EEG) remains, even after 80 years since its first conception by Hans Berger, the most powerful tool in our arsenal for delineating the epileptic foci, and is the primary tool in the selection and evaluation of presurgical candidates at most institutions. Additional data from neuroimaging modalities such as magnetic resonance imaging (MRI) also plays an indispensable role, and the validity of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET), ictal perfusion 99mTc-ethyl cysteinate dimer (ECD) single photon emission computed tomography (SPECT), and the more recently developed subtraction ictal SPECT coregistered to MRI (SISCOM) have all been proven in adult epileptic patients. [7] [8] [9] In pediatric patients, however, data on the effectiveness of these imaging modalities are still lacking, and even though most institutions employ these methods for their presurgical pediatric candidates, most researchers still state the need for further studies to verify the accuracy and effectiveness of these modalities in localizing the epileptogenic foci in immature brains. We have, therefore, accumulated epileptic surgical results from pediatric patients at our institution for the last four and a half years, and evaluated the effectiveness of various imaging modalities, encompassing MRI, PET, and SISCOM, for detecting the seizure foci as verified by surgical outcomes of temporal lobe lesions, which is most frequently the site of surgical treatment, and extratemporal lesions.
Materials and methods

Patients
All pediatric patients who were admitted to Severance Children's Hospital from October 2003 to April 2008 and received epilepsy surgery were evaluated. Patients who received focal lobectomies or cortisectomies after delineation of epileptic lesions were selected (Table 1) , and cases where precise localization of epileptic foci were possible through analysis of post-operative results, namely, patients with class I of Engel's classification of post-operative outcome, 10 were selected for enrollment in this study. Select patients were divided into temporal and extratemporal lesion groups in accordance to their epileptic foci, and the results of their presurgical EEG, MRI, FDG-PET, and SISCOM obtained from ictal and interictal ECD-SPECT were retrospectively analyzed (Table 2) . Post-operative pathological findings were also examined.
EEG
All candidates were examined by video-EEG monitoring in electroencephalographic monitoring unit (EMU) to search for the epileptogenic foci. The international 10-20 system was used for tracing. In patients whom surgical treatment was deemed possible, subsequent evaluation utilizing surgically placed subdural electrodes were carried out to further delineate the lesion. Surgical feasibility was discussed at a board meeting attended by specialists in child neurology, diagnostic radiology, and pediatric neurosurgery. Epileptogenic lesions were delineated primarily through interpretation of EEG data, and other imaging modalities were used to reinforce the results by labeling them as either concordant or discordant. In cases of conflicting results between evaluative modalities, extracranial EEG results were primarily used for determining the extent of subdural electrode placement, and direct cerebral monitoring results obtained by subdural electrodes were used to determine surgical resective margins.
MRI
Standard MRI was performed with conventional spin-echo T1-weighted sagittal, T2-weighted axial, flair axial, oblique coronal, and flair oblique coronal sequences, as well as with ultrafast gradient echo (TFE) T1-weighted 3D coronal sequences. A Philips MRI Achieva 3.0T Release 2.5.3.3 (USA) was used to acquire seizure-specialized sequences termed seizure phase 1 images, in accordance with the protocol described in Table 3 . In this study, 3D T1-weighted TFE magnetization-prepared rapid acquisition with gradient-echo sequence and both oblique coronal sequences with 3 mm thick sections were obtained from the oblique coronal plane of the temporal lobes perpendicular to the long axis of the hippocampus.
FDG-PET
PET images were acquired using a GE ADAVANCE PET Scanner (GE, Milwaukee, WI, USA) in 3D mode. The transaxial resolution of the system was 5.2 mm FWHM (full-width-half maximum) at the center of FOV (field of view). Approximately 5 mCi of 18 F-FDG was injected intravenously after 6 h of fasting, and patients were either sedated if uncooperative, or if cooperative, asked to lie still with their eyes closed in a quiet, dimly lit room during injection and following 40 min. The emission scan started at 40 min after injection and lasted 15 min, and an 8 min transmission scan was subsequently acquired for the purpose of attention correction. EEG was performed during FDG uptake using portable EEG with an international 10-20 system, and its tracing was later examined for presence of possible ictal discharges during acquisition of the images.
SISCOM
For acquisition of SISCOM images, patients underwent ictal and interictal single photon emission computed tomography (SPECT) studies at an interval of less than 1 week. As a radiotracer, approximately 740-925 MBq of technetium-99m ethyl cysteinate dimer (ECD) was administered intravenously. Continuous video EEG monitoring was performed at the EMU and the radiotracer was intravenously injected during the ictal period for acquisition of ictal SPECT. Seizure onset was defined as the time of earliest indication of auras or the beginning of the rhythmic ictal discharges on EEG. Seizure termination was defined as the time when ictal movement ceased or the time of termination of the ictal discharge. Brain images were obtained using a brain-dedicated annular crystal gamma camera (Digital Scintigraphic Incorporated, Waltham, MA) equipped with low-energy, high-resolution parallel-hole collimators. The full-width at half maximum (FWHM) of a high-resolution collimator is typically 7.5 mm at the center of rotation (COR) and 5.8 mm at the peripheral regions 9 cm from the COR. SPECT studies were acquired for 20 min in a 128 Â 128 matrix with 38 angular increments. Transaxial images were obtained by the filtered back-projection method using a Butterworth filter (cutoff frequency of 1.1 cycles/cm, order no. 10). Attenuation correction was performed by Chang's method after correcting for scatter by the dual-energy window method, and coronal and sagittal images were generated. After acquisition of ictal and interictal SPECT images, 32 transaxial slices of both ictal and interictal scans were reconstructed and each paired image was generated with the same orientation and level for the construction of subtraction images. Paired ictal and interictal transaxial images were normalized to the total counts, and interictal images were subtracted from ictal images on a CeraSPET workstation (Digital Scintigraphic Incorporated, Waltham, MA). Subtraction images were generated without applying a threshold and were qualitatively evaluated. Seizure localization was determined when pixels on ictal scans showed higher values than on interictal scans in corresponding regions. Table 2 Summary of patient specifics, duration of surgery, medical treatment, follow up, post-operative pathological findings, and concordance and localization abilities of analytical tools examined. 
Epileptic focus
Epileptic focus was defined as the area that resulted in seizure ablation upon resection.
Concordance and discordance
All evaluative tools were categorized into concordant and discordant groups. Concordance was defined as a tool's ability to localize epileptogenic lesions with precision, or failing that, at least lateralize lesions to a certain hemisphere. Failure of a diagnostic tool to visualize the epileptic foci, or presentation of excessively diffuse epileptic lesions to the extent that it makes it impossible to find the problematic area with precision were defined as ''discordant''.
Statistics
Each test was compared for the deduction of their lateralizing and localizing abilities in both extratemporal and temporal lesions, through calculation of their respective sensitivities. Fisher's exact test was used to compare concordance and localization power between the temporal lobe and extratemporal lobe by EEG, MRI, FDG-PET, or SISCOM in combination. The conjunctive lateralizing and localizing abilities of multiple modalities were calculated through Chi-square tests, and the statistical differences of their ability to find the epileptic foci in extratemporal and temporal areas were analyzed. SAS version 9.1 (SAS Inc., North Carolina) was utilized for this study, and p values <0.05 were considered statistically significant.
Results
From a total of 64 surgical cases, 42 patients were selected for enrollment. Nineteen patients received temporal lobectomies and 23 patients received extratemporal focal cortisectomies or lobectomies. All patients satisfied Engel's class I post-operative outcomes at the time of this study, as observed during a mean follow-up period of 2.15 years (0.59-5.05). Mean age of first seizure onset was 6.45 years (0.08-15.00), and the mean age of epilepsy surgery was 16.42 years (1.33-49.67). Patients were treated for an average of 9.96 years (0.50-37.67) before receiving surgery ( Table 2 ). Dual pathologies were absent in our cohort (Table 4) .
EEG
Long-term EEG monitoring was performed on all patients preoperatively for localization of the epileptogenic area. As our cohort only encompasses patients in whom epilepsy surgery was performed after determination of the surgical area by use of video-EEG monitoring, the concordance rate of EEG was 100%, both temporally and extratemporally. Epileptic foci in extratemporal regions showed 100% concordance with the EEG results, and in all cases, the lesion was well-localized to a specific operative area (sensitivity 1.000). In temporal lobe lesions, the concordance rate was 100% (sensitivity 1.000), but in five cases (patients 11, 13, 14, 15, and 18), EEG results were only lateralizing (localization in 78%, sensitivity 0.783). For these patients, further localization through employment of imaging modalities was necessary to target the lesion to a focal resective area (Fig. 1) . If EEG and imaging results proved discordant, as in patients 2, 12, 29, 30, and 31, EEG results were favored to determine operability.
MRI
MRI was performed in all patients, and was proven to be useful and sensitive in localizing epileptogenic lesions in both temporal and extratemporal areas. In extratemporal lesions, MRI showed a concordance rate of 84.2% (16/19 patients, sensitivity 0.842), with localization of the lesion in all concordant cases (84.2%, sensitivity 0.842). Discordance with the epileptic foci was seen in 15.8% of cases (3/19 patients). In temporal lesions, the concordance rate was 91.3% (21/23 patients, sensitivity 0.913), with localization of the lesion achieved in 82.6% (19/23 patients, sensitivity 0.826) and discordance in 2 cases (8.7%) (Fig. 2). 
FDG-PET
All patients with extratemporal lesion (19 patients) and 22 patients with temporal lobe lesions received FDG-PET studies. In extratemporal cases, FDG-PET showed concordance with the epileptic foci in 13 patients (13/19 patients, concordance rate 68.4%, sensitivity 0.684), with precise localization of lesions in 12 cases (12/19 patients, localization rate 63.2%, sensitivity 0.632), and discordance in six cases (31.6%). In temporal cases, FDG-PET was able to determine the epileptic foci in 21 patients (21/22 patients; concordance rate, 95.5%; sensitivity, 0.955), with precise localization in 16 cases (16/22 patients, localization rate 72.7%, sensitivity 0.727), and discordance in one case (4.5%) (Fig. 3) . Fig. 1 . Localization, lateralization, and discordance ratio of the epileptic foci for EEG.
SISCOM
In cases where ictal SPECT was acquired successfully, SISCOM images were constructed to minimize subjectivity, which is prone in visual analysis of nuclear medical images. SISCOM data were available in 13 extratemporal and 12 temporal cases. In extratemporal cases, SISCOM showed concordance with lesions in 12 cases (12/13 patients, 92.3%, sensitivity 0.923), and discordance in one case (7.7%), with precise localization in 11 cases (11/13 patients, 84.6%, sensitivity 0.846), which was almost equivalent to the localization power of the MRI images. In temporal lesions, SISCOM showed concordance in 12 cases (12/12 patients, 100%, sensitivity 1.000) and no cases with discordance (0%), but precise localization was achieved in eight patients only (8/12 patients, 66.7%, sensitivity 0.667), showing that its sensitivity in temporal area was lower than in extratemporal areas, and its sensitivity was inferior when compared to the sensitivity of corresponding PET images (Fig. 4) . Table 5 lists the sensitivity of each test in detecting epileptogenic areas, provided as ''concordant'' or ''localizing''. Considering that localizing power is more meaningful clinically, higher emphasis must be placed on localizing sensitivity than just concordance alone. It can be seen that MRI has high localization sensitivity in both extratemporal and temporal lesions, and in temporal lobes, its Fig. 2 . Localization, lateralization, and discordance ratio of epileptic foci for MRI. Fig. 3 . Localization, lateralization, and discordance ratio of epileptic foci for FDG-PET. Fig. 4 . Localization, lateralization, and discordance ratio of epileptic foci for SISCOM. sensitivity is higher than any other tests analyzed. PET has a low concordance and localization sensitivity in extratemporal regions, but showed a high concordance rate in temporal areas, and its localizing sensitivity in temporal areas approaches values observed with MRI. SISCOM has high concordance sensitivity in both temporal and extratemporal cases, but although the concordance rate is highest in temporal areas, the localizing ability is far lower in comparison, even when compared to other imaging modalities, while it is highly sensitive in extratemporal regions. Table 6 lists the p-values for the statistical differences of concordance and localization between temporal and extratemporal lesions by EEG and other imaging modalities in combinations, to verify the diagnostic values of combined modalities in temporal versus extratemporal lesions. It can be seen that with the sole exception of combined EEG and SISCOM data for localization of epileptic lesions, other modalities in combination failed to prove their usefulness in one specific region rather than in another.
Diagnostic values of MRI, FDG-PET, and SISCOM alone and in combination
Pathological findings
Differences in post-operative pathological results were notable between temporal and extratemporal cohorts. In temporal lobe patients, the most numerous pathology was hippocampal sclerosis with normal pathology in temporal cortex (16/23, 69.6%). Other findings were microdysgenesis (3/23, 13.0%), dysembryoplastic neuroepithelial tumor (DNET) (1/23, 4.3%), ganglioglioma (1/23, 4.3%), diffuse astrocytoma (1/23, 4.3%), and cortical dysplasia (1/ 23, 4.3%). In extratemporal patients, the most common finding was cortical dysplasia, accounting for 36.8% of the cases (7/19). Other findings included microdysgenesis (6/19, 31.6%), ganglioglioma (3/ 19, 15.8%), diffuse subpial gliosis (1/19, 5.3%), DNET (1/19, 5.3%), and a normal pathology in one case (5.3%).
Discussion
Recent employment of various nuclear imaging modalities such as FDG-PET, SPECT, and SISCOM has made delineation of epileptogenic zones easier and more accurate. Introduction of quantitative neuroimaging such as SISCOM and Statistical Parametric Mapping (SPM) in particular, have made nuclear image interpretation more objective. The value of quantitative neuroimaging has been shown to be equal to visual interpretation by trained specialists in adults, 8, 9 and recent studies by Lee et al. have hinted at its usefulness in pediatric populations 11 as well. A common belief in pediatric neurology holds that interictal hypometabolism, which is a requisite for obtaining accurate FDG-PET data, is lacking in pediatric patients, since interictal metabolic defect is related to the lifetime duration of seizures. 12 The effectiveness of interictal and ictal SPECT, as well as quantitative SISCOM data, still needs to be proven in pediatric patients, as their efficacy in immature brains has not yet been well described.
Our study shows that the localizing power of MRI is still highly accurate if the images are obtained with parameters specialized for detection of subtle cortical anomalies like gradient-echo sequences and Flair imaging, regardless of the location of the epileptic foci. FDG-PET and SISCOM were somewhat less universal in their efficacy, but their concordance with epileptic zones was almost equal to the concordance observed in adults. 13 FDG-PET was highly concordant with epileptic lesions in the temporal area, which, at 92%, approached the sensitivity of MRI. Localizing sensitivity was also high at 73%, approaching the sensitivity seen with MRI and surpassing SISCOM sensitivity in temporal lobe lesions. In extratemporal lesions, however, FDG-PET was unreliable as its discordance rate was over 30%, and even though the lateralization rate was only 5%, compared to a lateralizing rate of 19% in temporal lobe lesions, its localizing rate was a mere 63%, which translated to it being the least sensitive among imaging modalities analyzed.
SISCOM data was useful in detecting pathologic lesions in extratemporal locations, with a concordance rate of 92.3% and localization of 84.6%, which is higher than any imaging tools analyzed. Discordance was seen in only 7.7% of cases, which showed that SISCOM analysis is highly sensitive in identifying epileptogenic lesions with precision. In temporal lesions, SISCOM showed a concordance rate of 100%, but these results contained a relatively high portion of lateralizing results in 33.3% of cases and localization was achieved in a mere 66.7%, which was inferior to PET analysis in detecting pathologic lesions in this particular region.
Pathological results revealed mostly hippocampal sclerosis with normal cortical tissue in temporal lesions and cortical dysplasia or microdysgenesis in extratemporal lesions. This difference in underlying pathology could be the reason behind the varying effectiveness of PET and SISCOM in different regions, but comparative studies on the effectiveness of PET versus SISCOM in different pathological settings are currently lacking, and further studies into this field are warranted.
When the tests were analyzed in combination to verify their localizing superiority in one region compared to another, no statistical differences were found between the various groups tested, except for EEG and SISCOM in combination, which is probably indicative of the better analytical ability of these modalities in detecting lesions in the extratemporal lobe, the best site in terms of efficacy for SISCOM.
Hence, it could be deduced that ruling out a certain imaging test by location of the lesion is not practical, but further study employing larger subsets of samples is required to ascertain this hypothesis. Singularly, certain imaging modalities have been shown to be more sensitive in certain regions, with MRI being useful in both temporal and extratemporal lesions. As a tool to supplement electrographical results, imaging modalities exhibit satisfactorily high concordance and localizing sensitivity, with low rates of discordance, proving that they are invaluable assets in supplementing data obtained from long-term EEG monitoring. FDG-PET was as reliable as MRI in localizing epileptogenic lesions in temporal lobe cases, even in our pediatric group with a mean duration of lifetime seizure of 9.67 years. Efficacy of FDG-PET imaging was lower in extratemporal lobe lesions. SISCOM, on the other hand, could be counted on to determine the epileptogenic area in extratemporal lobes with precision that is matched only by MRI, while its efficacy was inferior to other modalities in temporal areas. Hence, we determined that in cases of confounding pre-surgical results, MRI, with supplementary data from PET, would help a physician in establishing correct diagnosis in temporal lobe epilepsies, while utilization of MRI and SISCOM data would be wiser in extratemporal cases. There were also profound differences in post-surgical pathology between the two regions analyzed, and this may be the reason behind the differing efficacy of each imaging modalities in different parts of the brain, but more studies are needed.
Our study was limited in that only three cases of occipital lobe epilepsy and two cases of parietal lobe epilepsy were included, making most of the samples either frontal lobe seizures or temporal lobe seizures. Further studies employing a larger group of patients would be required to determine the efficacy of each imaging modality in specific lobes of the cerebral hemisphere.
There is also the possibility that the localizing power of these imaging modalities might be different in patients with less favorable surgical outcomes; namely, patients with Engel class II-IV postoperative outcomes. However, due to lack of means to locate the epileptogenic region in this group of patients with precision, direct comparison of this data with our result is meaningless under this study's design, and separate studies exploring the results of imaging modalities in poorly treated patients are needed.
Conclusion
The localizing power of FDG-PET in pediatric patients was greatest in the temporal lobe, while SISCOM exhibited its greatest localizing ability in the extratemporal lesions. MRI showed the greatest versatility and highest accuracy in localizing epileptogenic areas in both temporal and extratemporal areas. Various analytical tools in combination failed to show any statistical differences at better localizing a pathologic lesion in temporal or extratemporal regions, except for combinations of EEG and SISCOM, which were statistically relevant for better differentiation of lesions in the extratemporal area.
